Kaul DK, Fabry ME, Suzuka SM, Zhang X. Antisickling fetal hemoglobin reduces hypoxia-inducible factor-1␣ expression in normoxic sickle mice: microvascular implications. Am J Physiol Heart Circ Physiol 304: H42-H50, 2013. First published November 2, 2012; doi:10.1152/ajpheart.00296.2012.-Chronic inflammation is a salient feature of sickle cell disease (SCD) and transgenic-knockout sickle (BERK) mice. Inflammation is implicated in the activation of hypoxia-inducible factor-1␣ (HIF-1␣) under normoxic conditions. We hypothesize that, in SCD, inflammation coupled with nitric oxide (NO) depletion will induce expression of HIF-1␣, a transcription factor with wide-ranging effects including activation of genes for vasoactive molecules. To this end, we have examined the expression of HIF-1␣ in normoxic BERK mice expressing exclusively human ␣-and  S -globins, and evaluated the effect of fetal hemoglobin (HbF) in BERK mice (i.e., Ͻ1.0%, 20%, and 40% HbF). HbF exerts antisickling and anti-inflammatory effects. Here, we show that HIF-1␣ is expressed in BERK mice under normoxic conditions, accompanied by increased expression of its vasoactive biomarkers such as VEGF, heme oxygenase-1 (HO-1), and serum ET-1 levels. In BERK mice expressing HbF, HIF-1␣ expression decreases concomitantly with increasing HbF, commensurately with increased NO bioavailability, and shows a strong inverse correlation with plasma NO metabolites (NOx) levels. Reduced HIF-1␣ expression is associated with decreased HO-1, VEGF, and ET-1. Notably, arteriolar dilation, enhanced volumetric blood flow, and low blood pressure in normoxic BERK mice all show a trend toward normalization with the introduction of HbF. Also, arginine treatment reduced HIF-1␣, as well as VEGF expression in normoxic BERK mice, supporting a role of NO bioavailability in HIF-1␣ activation. Thus HIF-1␣ expression in normoxic sickle mice is likely a consequence of chronic inflammation, and HbF exerts an ameliorating effect by decreasing sickling, increasing NO bioavailability, and reducing inflammation. sickle cell disease; hypoxia-inducible factor-1␣; fetal hemoglobin; nitric oxide; oxidative stress; inflammation HEMOGLOBIN S (HBS) polymerization under deoxygenated conditions and abnormal red blood cell rheology are central to the pathophysiology of sickle cell disease (SCD), the consequences of which can lead to vaso-occlusion, reperfusion injury, oxidative stress, hemolysis, reduced nitric oxide (NO) bioavailability, and inflammation (15,19,25,41). In SCD, vaso-occlusive events may result in episodes of tissue ischemia. Tissue ischemia is normally associated with the activation of hypoxia-inducible factor-1␣ (HIF-1␣). Under normoxic conditions, HIF-1␣ expression can be triggered by inflammation (26, 55), a prominent feature of human SCD and transgenic sickle mice (24). Activation of HIF is implicated in cellular adaptive responses to hypoxia and inflammation. HIF can trigger transcription of genes for vasoactive molecules such as vascular endothelial growth factor (VEGF), heme oxygena...